In the future, it will be possible to identify the cause and origin of diseases, which will enable the administering of specific treatments. A major impact in terms of diagnostics is likely to be from the development of rapid, less expensive, and point-of-care diagnostic tests to investigate molecular conditions. These will be of increasing importance in primary care at people’s homes, and also to the developing nations that have poor medical care systems as well as increased incidence of diseases.
Frost & Sullivan (ti.frost.com) finds that Rapid Test Kits for Patient Diagnostics provides in-depth information about the various commercial products and technologies developed for rapid screening of various health conditions. Rapid Test Kits are used in testing for infectious diseases and metabolic disorders. Additionally, they are used for pregnancy testing, drug abuse, heavy metal toxicity testing, genetic testing, and elated health complications. The study provides information on various products and technologies available in the market today and those on the verge of commercialization.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the Rapid Test Kits for Patient Diagnostics, then send an email to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, and country. We will send you the information via email upon receipt of the above information.
"The dynamic nature of the growing number of infective agents and the absence of specific and efficient treatments for several viral, bacterial and genetic diseases has created the need for rapid identification and diagnosis," says Frost & Sullivan Research Analyst Sangeetha Prabakar. "The ability of rapid test methods to give real-time results within minutes, as compared to hours of lab testing increases their acceptance and usage by the medical community as it saves time for both patient and physician."
Innovations such as the development of multiple assays for simultaneous testing of different diseases results in cost and time saving, apart from providing reliable and accurate results. Furthermore, the development of simple-to-use and minimally invasive or non-invasive test kits aid in increasing their patient usage at the convenience of their homes. Moreover, advances in bio-diagnostics such as the DNA diagnostics, are driving the market for rapid tests.
However, developing rapid diagnostic test products requires huge amounts of time and experimentation, especially to identify the disease marker before developing and commercializing a suitable diagnostic platform. This necessitates undeterred commitment and huge investments for R&D, as it usually takes several years to commercialize a rapid test. Hence, test developers need to focus initially on the discovery of the unexplored markers.
"Commercial test kits must be made available to the end-user at affordable costs," explains Prabakar. "As the initial development of these tests requires huge investment capital, the commercial product costs higher once it enters the market but with the demand for lower prices, manufacturers are forced to suffocate their profit margins."
There is a huge demand for rapid tests in a variety of end-user areas. However, manufacturers still need to focus on their ability to sufficiently cater to the needs of a broader market including pediatrics, neonatal screening, and rapid screening of emerging and contagious infectious diseases. Moreover, they need to concentrate on disease specific product marketing in a particular geographical area. For example, in a region with malaria incidence, people should have immediate access to affordable rapid malaria tests which is likely to boost the revenue potential.
Rapid Test Kits for Patient Diagnostics is part of the Technical Insights Subscription, and it includes a thorough examination of the following technologies: microarrays, biosensors, polymerase chain reaction (PCR), immunoassays, and lab-on-chip tests. Interviews are available to the press.
Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and research services.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics.